Karin Hehenberger, M.D., Ph.D.
DirectoratWhitehawk Therapeutics· In proxies 2023–2025
Karin Hehenberger, M.D., Ph.D. is Director of Whitehawk Therapeutics.
Experience
- Whitehawk TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -71%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?